VANCOUVER, British Columbia – Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that the Company is taking steps to strategically refocus its resources and has implemented a company-wide cost-cutting initiative. As a result, the Company is expecting expense reductions of approximately $2 million in 2011 based on current sales levels. This $2 million savings […]
Basel – Flexible “Intelligent LabPower” system helps labs increase efficiency, lets them reconfigure modules for changing needs Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum Work Area solution designed for diagnostic laboratories […]
PLEASANTON, Calif. – QuantaLife, a new life science tool company developing the third generation of PCR, has received an NIH grant totaling ~$6 million over 5 years for the development of rapid, cost-effective technology for detecting methicillin-resistant Staphylococcus aureus (MRSA) infections. The grant, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of […]
ROCKVILLE, Maryland and SEOUL, Korea – Seegene today announced its successful initial public offering on the KOSDAQ (Korea Securities Dealers Automated Quotations). The company sold 636,500 shares for USD 26.16 (WON 30,500) each, raising USD 16.6 million and giving Seegene a market capitalization of USD 167 million. The company plans to invest the fresh capital […]
CLC bio, AROS Applied Biotechnology, F. Hoffmann-La Roche, and Aarhus University Hospital – the Institute of Pathology and the Research Unit for Molecular Medicine, announced a collaboration to develop a solution for large scale use of formalin fixed, paraffin embedded (FFPE) tissue in molecular analyses. The project goal is to develop a complete platform for […]
Oxford, UK – Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today introduced the groundbreaking CytoSure™ ISCA UPD 4 x 180k array. This offers the ability, for the first time, to simultaneously detect DNA copy number variation (CNV) using OGT’s ISCA consortium endorsed 4 x 180k […]
SUNNYVALE, Calif. – Cepheid (Nasdaq: CPHD) today announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.” The complete study is now available online (https://www.nejm.org) and will appear in the September 9 […]
Glasgow, Scotland – Renishaw Diagnostics Ltd, a world leading provider of trace level detection technologies based on the exploitation of Surface Enhanced Raman Spectroscopy (SERS) and Surface Enhanced Resonance Raman Scattering (SERRS) for clinical research and molecular diagnostics applications, today held its official opening of expanded premises on the Nova Technology Park. The company (previously […]
QIAsymphony RGQ System scores with highest possible flexibility and the broadest available range of PCR-based test systems Hilden, Germany, and Germantown, MD. – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched its novel QIAsymphony RGQ system. The automated platform has been specifically designed to address the fast-growing molecular diagnostics market, particularly for applications […]
Austin, Texas – Asuragen, Inc., a leader in molecular diagnostics and nucleic acid-based pharmacogenomics services, announced today that it has launched KRAS and BRAF mutational testing services in its CAP-accredited CLIA laboratory. Asuragen’s KRAS and BRAF laboratory developed tests (LDTs) were designed in response to newly modified guidelines from the American Society of Clinical Oncology […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
